Peptide Biomaterials for Pharmaceutical Applications
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: 25 March 2025 | Viewed by 695
Special Issue Editors
Interests: nanomedicine; nanomaterials; nanotoxicology; drug delivery systems; biomaterials
Special Issues, Collections and Topics in MDPI journals
Interests: nanomedicine; biomaterials; drug delivery systems; pharmaceutical technology; cosmetic development
Special Issue Information
Dear Colleagues,
Peptides are small molecules consisting of a couple or several amino acids coupled through peptide bonds. They have important uses in living organisms as hormones and chemical messengers and can be used for the design of novel therapies and innovative pharmaceuticals. The emergence of innovative engineered proteins, peptide biopolymers and peptide-based biomaterials for novel drug delivery, drug development, biosensors or tissue regeneration has encountered important challenges, such as their chemical and physical fragility (rapid degradation), poor or limited solubility and scarce permeability.
The aim of this Special Issue is to offer to our readers an updated and comprehensive glimpse of the recent in vitro and in vivo uses of peptide-based biomaterials for pharmaceutical applications. We invite full papers, communications and reviews covering topics related to the keywords below.
Dr. Miguel Mendez-Rojas
Dr. Sergio Alberto Bernal Chavez
Dr. Sergio Alcalá Alcalá
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- peptides
- pharmaceutical applications
- nanomedicine
- peptide materials
- peptide conjugates
- drug delivery systems
- nanocarriers
- biologics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
